Navigation Links
9.50mm diameter Corneal Trephine Blades

Products9.50mm diameter Corneal Trephine Blades
Company Medtronic Xomed, Inc.
Item 9.50mm diameter Corneal Trephine Blades
Features 
Description Medtronic Ophthalmics offers a comprehensive selection of corneal trephine blades and handles. Handcrafted, sharp, uniform blade edges promote a symetrical and vertical cut of all corneal layers.
Info Medtronic Xomed, Inc.
Customer Service: (800) 874-5797
Web site: http://www.xomed.com/

Related medicine products :

1. 5.00mm diameter Corneal Trephine Blades
2. 4.00mm diameter Corneal Trephine Blades
3. 5.5mm diameter Corneal Trephine Blades
4. 6.00mm diameter Corneal Trephine Blades
5. 6.25mm diameter Corneal Trephine Blades
6. 6.5mm diameter Corneal Trephine Blades
7. 6.75mm diameter Corneal Trephine Blades
8. 7.00mm diameter Corneal Trephine Blades
9. 7.75mm diameter Corneal Trephine Blades
10. 7.25mm diameter Corneal Trephine Blades
11. 7.50mm diameter Corneal Trephine Blades
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products:
(Date:11/5/2009)... Teaneck, NJ/ - November 3, 2009 The Cornea and ... study to determine if an investigational corneal ...or reading glasses. Dr. Peter Hersh, the study do...igational AcuFocus Corneal Inlay (ACI) is intende...ia, which is the loss of near vision, and reduce d...
(Date:11/5/2009)... Emdat, a world leader in on... Olver as its new CEO, effective immediately. , ... Emdat , a world leader in online-based medical t...O, effective immediately., , , , ,Emdat’s f...the business, selected Olver to serve as CEO of th...
(Date:11/5/2009)..., CHICAGO, Nov. 5 STINSON Brand I...ursing" by Florence Nightingale in recognition of ..., The e-book is one in a series of e-books titl.... The book can be downloaded for no charge at htt...sOnNursing.htm ,, "This is a way we celebrate ...
(Date:11/5/2009)... drug already approved for the treatment of lympho...e cancer in children and teens, according to an ea...ernational Journal of Cancer . The study drug, Bor...ncer in human cancer cell studies and in mice. Whi...died closely resembled the human form and the drug...
(Date:11/5/2009)...vey finds poorer results, higher costs than in oth...hDay News) -- The United States lags behind other ...tices, according to a new international survey of ... any of the other countries in the survey, yet a m...ients often can,t afford care, and a wide majority...
Breaking Medicine News(10 mins):Health News:Near vision research study 2Health News:Randy Olver Named Emdat CEO, Will Lead Next Phase of Growth for Medical Transcription Solutions Provider 2Health News:National Nurse Practitioner Week Recognized by STINSON Brand Innovation With Offer of 'Notes on Nursing' e-book 2Health News:Approved lymphoma drug shows promise in early tests against bone cancer 2Health News:Doctors Point Out Gaps in U.S. Health Care 2
...Dutch study of tibolone, also used for osteoporosi... to increased risk, , , TUESDAY, Feb. 17 (...ug used to treat menopausal symptoms and to preven...survivors of the disease. , Tibolone isn,t availab...
..., Residents at risk for chronic kidney disease urg... kidney disease (CKD), which affects 20 million pe...he U.S. and it is growing at a steady and alarming... signs or symptoms until the kidneys are about to ...
..., Showboat Atlantic City Hotel and Casino will hos...Campaign Award Reception , , ATLANTIC CITY, N.J.,...Atlantic City Hotel are teaming up on Wednesday, F...20090217/DC71647LOGO ) , (Logo: http://www.newsc...
..., Alcohol and iron are believed to have a synergi...rthermore, alcohol enhances iron absorption. Prima...esulting from mutations in the HFE gene, with a di...between iron metabolism, HFE mutations and alcohol...
..., New Orleans, LA Michael Lan, PhD, Professor o...enter New Orleans, is the senior author of a paper...n determines the fate of the cells that make and r...y available online, will be published in the Jour...
..., Peritoneal carcinomatosis can be thought of as ... metastatic cascade. The peritoneal stromal tissue...ation, providing a rich source of growth factors a...y understood. Astragalus memebranaceus,a tradition...
Other Medicine News:Health News:Menopause Drug Tied to Breast Cancer Recurrence 2Health News:Task Force Alerting Nevadans to 'Silent' Killer Disease Crisis 2Health News:The American Red Cross Recognizes Atlantic City Casinos 2Health News:LSUHSC research may benefit diabetes by increasing understanding of how to control islet cell growth 2Health News:An adjuvant chemotherapeutic agent in gastric cancer therapy 2
(Date:11/5/2009)...ELL, Wash., Nov. 5 Car...bal leader in automated external defibrillator ( ...announced today it appointed veteran healthcare ex...rectors. Andrews replaces long-time board member J...oard seat effective November 5th. The total number...
(Date:11/5/2009)...SBAD, Calif., Nov. 5 Gen...tory services provider, today reported revenues of...h includes a $4.4 million benefit from changes in ...ng cash collections related to prior period revenu...ue of $32.1 million for the comparable period in 2...
(Date:11/5/2009)...TLE, Nov. 5 Trubion Phar... financial results for its third quarter and nine ...www.newscom.com/cgi-bin/prnh/20090320/TRUBIONLOGO ...ial Results ,, Revenue for the third quarter ...lion and $12.8 million, respectively, compared wit...
Breaking Medicine Technology:Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 2Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 3Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 4Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 5Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 2Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 3Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 4Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 5Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 7Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 8Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 9Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 10Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 11Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 2Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 3Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 4Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 5Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 6Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 7Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 1Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 2Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 3Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 4Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 5Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 6Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 7Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 8UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 1UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 2CSHL led team discovers rare mutation dramatically increasing schizophrenia risk 10513 1CSHL led team discovers rare mutation dramatically increasing schizophrenia risk 10513 2